• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

芬兰帕金森病的流行病学

Epidemiology of Parkinson's disease in Finland.

作者信息

Marttila R J, Rinne U K

出版信息

Acta Neurol Scand. 1976 Feb;53(2):81-102. doi: 10.1111/j.1600-0404.1976.tb04328.x.

DOI:10.1111/j.1600-0404.1976.tb04328.x
PMID:1266565
Abstract

This investigation was conducted to clarify the epidemiology of Parkinson's disease in Finland. A community survey was made in a selected area in southwest Finland in addition to an analysis of Finnish mortality statistics for Parkinson's disease. The annual mortality rate from Parkinson's disease was found to average 2 per 100,000 population. Almost 70 per cent of the deaths occurred between 65-79 years of age. The total and age-specific mortality rates for males were greater than those for females whereas the proportionate mortality rates were almost identical. This was considered to indicate that suggestions of greater male prevalence, based on mortality statistics, do not appear justified. On prevalence day, Dec. 31st, 1971, 484 patients with Parkinson's disease (of which 444 were personally examined) lived in the area of investigation (population 402,988), the prevalence rate being 120.1 per 100,000 population. The highest annual incidence rate was 16.6 per 100,000 population. The age-specific prevalence rates showed a rapid increase after the 50th year of age. The greatest prevalence was shown by the age group 70-79 years of age in which almost 0.8 per cent of the population are affected. Age-specific incidence rates also displayed an increase after the 50th year of age. The greatest incidence was observed in the age group 70-79 years of age in which almost 1 per 1,000 of the population are annually affected by the disease. A difference between the sexes was demonstrable in the prevalence and incidence rates showing greater values for females, but in the age-specific frequencies the differences were reduced. This probably reflects the difference between the age structures of the male and female populations, suggesting that both sexes have a similar risk of being affected by the disease. The permanent age structure shown by idiopathic patients in comparison with previous investigations as well as the increased mean age and proportionate decrease of postencephalitic patients was found to be in disagreement with the cohort theory according to which all parkinsonian patients are previously victims of encephalitis lethargica.

摘要

本次调查旨在阐明芬兰帕金森病的流行病学情况。除了分析芬兰帕金森病死亡率统计数据外,还在芬兰西南部一个选定地区进行了社区调查。发现帕金森病的年死亡率平均为每10万人口2例。近70%的死亡发生在65至79岁之间。男性的总死亡率和年龄别死亡率高于女性,而比例死亡率几乎相同。这被认为表明,基于死亡率统计得出的男性患病率更高的说法似乎没有依据。在1971年12月31日患病率调查日,484例帕金森病患者(其中444例接受了个人检查)生活在调查区域(人口402,988),患病率为每10万人口120.1例。最高年发病率为每10万人口16.6例。年龄别患病率在50岁以后迅速上升。患病率最高的是70至79岁年龄组,该组几乎0.8%的人口受影响。年龄别发病率在50岁以后也有所上升。发病率最高的是70至79岁年龄组,该组每年几乎每1000人中有1人受该疾病影响。在患病率和发病率方面,性别差异明显,女性的值更高,但在年龄别频率方面,差异有所减小。这可能反映了男性和女性人口年龄结构的差异,表明两性受该疾病影响的风险相似。与之前的调查相比,特发性患者显示出的固定年龄结构以及平均年龄的增加和脑炎后患者比例的相应下降,与队列理论不一致,根据队列理论,所有帕金森病患者以前都是昏睡性脑炎的受害者。

相似文献

1
Epidemiology of Parkinson's disease in Finland.芬兰帕金森病的流行病学
Acta Neurol Scand. 1976 Feb;53(2):81-102. doi: 10.1111/j.1600-0404.1976.tb04328.x.
2
Epidemiology of Parkinson's disease--an overview.帕金森病的流行病学——概述
J Neural Transm. 1981;51(1-2):135-48. doi: 10.1007/BF01664011.
3
Changing epidemiology of Parkinson's disease in southwestern Finland.芬兰西南部帕金森病流行病学的变化
Neurology. 1999 Jan 15;52(2):302-8. doi: 10.1212/wnl.52.2.302.
4
Familial aggregation of Parkinson's disease in a Finnish population.芬兰人群中帕金森病的家族聚集性。
J Neurol Neurosurg Psychiatry. 2000 Jul;69(1):107-9. doi: 10.1136/jnnp.69.1.107.
5
Prevalence of Parkinson's disease in Estonia.爱沙尼亚帕金森病的患病率。
Acta Neurol Scand. 2002 Nov;106(5):276-81. doi: 10.1034/j.1600-0404.2002.01286.x.
6
The frequency of idiopathic Parkinson's disease by age, ethnic group, and sex in northern Manhattan, 1988-1993.1988 - 1993年曼哈顿北部特发性帕金森病按年龄、种族和性别的发病频率。
Am J Epidemiol. 1995 Oct 15;142(8):820-7. doi: 10.1093/oxfordjournals.aje.a117721.
7
Parkinson's disease in a nationwide twin cohort.全国双胞胎队列中的帕金森病
Neurology. 1988 Aug;38(8):1217-9. doi: 10.1212/wnl.38.8.1217.
8
Disability and progression in Parkinson's disease.
Acta Neurol Scand. 1977 Aug;56(2):159-69. doi: 10.1111/j.1600-0404.1977.tb01420.x.
9
Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan.城乡帕金森病患病率的差异:台湾一项基于人群的研究。
Neuroepidemiology. 2009;33(4):350-7. doi: 10.1159/000254572. Epub 2009 Nov 4.
10
The prevalence and incidence of Parkinson's disease.
Geriatrics. 1970 May;25(5):128-33.

引用本文的文献

1
Role of 6-Fluoro-18F-l-3,4-DOPA MR-PET in Clinical Workup in Movement Disorders Cases: An Exploratory Study in a Tertiary Care Neuropsychiatric Setup.6-氟-18F-左旋-3,4-二羟基苯丙氨酸磁共振正电子发射断层显像在运动障碍病例临床检查中的作用:三级神经精神科机构的探索性研究
Indian J Nucl Med. 2025 Jan-Feb;40(1):10-15. doi: 10.4103/ijnm.ijnm_151_23. Epub 2025 May 16.
2
Adult-Onset Neuroepidemiology in Finland: Lessons to Learn and Work to Do.芬兰的成人发病神经流行病学:可汲取的经验教训与待开展的工作
J Clin Med. 2023 Jun 11;12(12):3972. doi: 10.3390/jcm12123972.
3
Sex Differences in Dopaminergic Vulnerability to Environmental Toxicants - Implications for Parkinson's Disease.
环境毒物致多巴胺能神经元易损性的性别差异-对帕金森病的启示。
Curr Environ Health Rep. 2022 Dec;9(4):563-573. doi: 10.1007/s40572-022-00380-6. Epub 2022 Oct 6.
4
Dopamine transporter (DAT) imaging in Parkinson's disease and related disorders.帕金森病及相关疾病中多巴胺转运体(DAT)的影像学研究。
J Neural Transm (Vienna). 2022 Jun;129(5-6):581-594. doi: 10.1007/s00702-021-02452-7. Epub 2021 Dec 15.
5
An update on the management of young-onset Parkinson's disease.青年帕金森病管理的最新进展。
Degener Neurol Neuromuscul Dis. 2013 Oct 4;2:53-62. doi: 10.2147/DNND.S34251. eCollection 2013.
6
PET Imaging in Movement Disorders.正电子发射断层扫描(PET)在运动障碍疾病中的应用
Semin Nucl Med. 2018 Nov;48(6):513-524. doi: 10.1053/j.semnuclmed.2018.07.006. Epub 2018 Aug 16.
7
Chinese culture permeation in the treatment of Parkinson disease: a cross-sectional study in four regions of China.中国文化渗透于帕金森病治疗中的研究:一项在中国四个地区开展的横断面研究
BMC Res Notes. 2014 Jan 30;7:65. doi: 10.1186/1756-0500-7-65.
8
Translation and validation of the korean version of the 39-item Parkinson's disease questionnaire.帕金森病 39 项问卷韩文版的翻译与验证。
J Clin Neurol. 2013 Jan;9(1):26-31. doi: 10.3988/jcn.2013.9.1.26. Epub 2013 Jan 3.
9
Neuropsychology, neuroimaging or motor phenotype in diagnosis of Parkinson's disease-dementia: which matters most?神经心理学、神经影像学或运动表型在帕金森病痴呆的诊断中:哪个最重要?
J Neural Transm (Vienna). 2012 May;119(5):597-604. doi: 10.1007/s00702-011-0733-3. Epub 2011 Dec 13.
10
Steroids-dopamine interactions in the pathophysiology and treatment of CNS disorders.甾体类药物与多巴胺在中枢神经系统疾病的病理生理学和治疗中的相互作用。
CNS Neurosci Ther. 2010 Jun;16(3):e43-71. doi: 10.1111/j.1755-5949.2010.00163.x.